Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
402.05 GBX | +3.42% |
|
+6.01% | +2.30% |
Jul. 11 | European stocks down with bank and healthcare drag, US-EU tariffs in focus | RE |
Jul. 11 | FTSE 100 retreats from peak as growth concerns weigh | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -4.9 | 2.93 | 9.23 | 5.82 | 2.32 | |||||
Return on Total Capital | -7.98 | 4.96 | 17.78 | 11.53 | 4.38 | |||||
Return On Equity % | -22.26 | 9.64 | -1.56 | 18.85 | 1.5 | |||||
Return on Common Equity | -23.94 | 10.31 | -3.48 | 22.12 | 0.6 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.3 | 24.29 | 29.27 | 30.74 | 25.03 | |||||
SG&A Margin | 5.79 | 7.61 | 5.58 | 7.93 | 8.67 | |||||
EBITDA Margin % | 6.79 | 15.02 | 22.63 | 21.19 | 14.39 | |||||
EBITA Margin % | -12.04 | 8.57 | 17.93 | 13.06 | 6.02 | |||||
EBIT Margin % | -12.25 | 8.3 | 17.72 | 12.7 | 5.57 | |||||
Income From Continuing Operations Margin % | -11.51 | 5.41 | -0.57 | 7.62 | 0.66 | |||||
Net Income Margin % | -11.27 | 4.82 | -1.04 | 7.31 | 0.2 | |||||
Net Avail. For Common Margin % | -11.28 | 4.82 | -1.04 | 7.31 | 0.21 | |||||
Normalized Net Income Margin | -8.19 | 5.67 | 10.89 | 7.5 | 3.47 | |||||
Levered Free Cash Flow Margin | 8.34 | 8.82 | 18.34 | 7.94 | 9.15 | |||||
Unlevered Free Cash Flow Margin | 9.09 | 9.54 | 18.82 | 8.83 | 10.34 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.64 | 0.57 | 0.83 | 0.73 | 0.67 | |||||
Fixed Assets Turnover | 1.46 | 1.38 | 2.19 | 1.98 | 1.83 | |||||
Receivables Turnover (Average Receivables) | 10.77 | 8.7 | 9.27 | 7.59 | 7.75 | |||||
Inventory Turnover (Average Inventory) | 8.18 | 5.85 | 6.55 | 5.67 | 6.1 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.22 | 1.15 | 1.09 | 1.21 | 1.25 | |||||
Quick Ratio | 0.83 | 0.73 | 0.76 | 0.9 | 0.88 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.29 | 0.41 | 0.37 | 0.33 | |||||
Days Sales Outstanding (Average Receivables) | 33.98 | 41.97 | 39.39 | 48.09 | 47.2 | |||||
Days Outstanding Inventory (Average Inventory) | 44.76 | 62.4 | 55.74 | 64.38 | 59.99 | |||||
Average Days Payable Outstanding | 69.29 | 93.06 | 93.76 | 125.11 | 112.7 | |||||
Cash Conversion Cycle (Average Days) | 9.45 | 11.31 | 1.37 | -12.64 | -5.51 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 95.74 | 77.16 | 66.87 | 73.78 | 91.35 | |||||
Total Debt / Total Capital | 48.91 | 43.56 | 40.07 | 42.46 | 47.74 | |||||
LT Debt/Equity | 82.55 | 69.09 | 60.48 | 66.84 | 82.25 | |||||
Long-Term Debt / Total Capital | 42.17 | 39 | 36.24 | 38.46 | 42.98 | |||||
Total Liabilities / Total Assets | 68.03 | 68.52 | 71.2 | 69.5 | 72.25 | |||||
EBIT / Interest Expense | -10.22 | 7.14 | 22.95 | 8.93 | 2.93 | |||||
EBITDA / Interest Expense | 6.73 | 14.02 | 30.37 | 15.78 | 8.36 | |||||
(EBITDA - Capex) / Interest Expense | 1.03 | 8.04 | 23.85 | 10.96 | 4.07 | |||||
Total Debt / EBITDA | 5.64 | 2.73 | 0.99 | 1.35 | 2.4 | |||||
Net Debt / EBITDA | 3.5 | 1.53 | 0.26 | 0.37 | 0.91 | |||||
Total Debt / (EBITDA - Capex) | 36.94 | 4.77 | 1.26 | 1.94 | 4.92 | |||||
Net Debt / (EBITDA - Capex) | 22.9 | 2.67 | 0.33 | 0.53 | 1.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -35.03 | 48.37 | 52.91 | -12.85 | -10.06 | |||||
Gross Profit, 1 Yr. Growth % | -44.06 | 47.92 | 84.22 | -7.83 | -26.77 | |||||
EBITDA, 1 Yr. Growth % | -61.57 | 92.46 | 130.56 | -17.58 | -38.94 | |||||
EBITA, 1 Yr. Growth % | -311.64 | -161.94 | 220.23 | -35.67 | -58.56 | |||||
EBIT, 1 Yr. Growth % | -322.45 | -158.96 | 226.97 | -36.7 | -60.53 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -594.73 | -140.94 | -115.99 | -1.27K | -92.26 | |||||
Net Income, 1 Yr. Growth % | -604.35 | -137.26 | -132.88 | -712.75 | -97.5 | |||||
Normalized Net Income, 1 Yr. Growth % | -317.32 | -160.25 | 194.08 | -40.13 | -58.42 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -608.97 | -137.17 | -135.1 | -755.19 | -97.3 | |||||
Accounts Receivable, 1 Yr. Growth % | -33.99 | 71.21 | 27.18 | -9.92 | -14.24 | |||||
Inventory, 1 Yr. Growth % | -19.19 | 40.53 | 18.43 | -18.74 | 1.81 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -13.42 | -1.68 | -6.07 | -1.25 | -4.28 | |||||
Total Assets, 1 Yr. Growth % | -9.33 | 7.33 | 0.3 | -2.72 | 0.69 | |||||
Tangible Book Value, 1 Yr. Growth % | -25.82 | 7.52 | -19.86 | 5.35 | -27.42 | |||||
Common Equity, 1 Yr. Growth % | -27.61 | 5.91 | -10.48 | 4.04 | -15.71 | |||||
Cash From Operations, 1 Yr. Growth % | -52.81 | 94.15 | 73.35 | -21.73 | -14.8 | |||||
Capital Expenditures, 1 Yr. Growth % | -20.18 | -11.53 | 10.86 | 18.36 | 7.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 177.4 | -7.99 | 218.35 | -62.01 | 332.72 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 136.4 | -8.62 | 201.85 | -58.85 | 233.24 | |||||
Dividend Per Share, 1 Yr. Growth % | -36.36 | -17.6 | 11.34 | 18.01 | 10.03 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -22.2 | -0.42 | 50.62 | 15.41 | -11.47 | |||||
Gross Profit, 2 Yr. CAGR % | -24.66 | -9.03 | 65.08 | 30.29 | -17.84 | |||||
EBITDA, 2 Yr. CAGR % | -38.63 | -16.87 | 93.83 | 32.48 | -30.33 | |||||
EBITA, 2 Yr. CAGR % | 17.14 | -7.38 | 102.89 | 46.74 | -47.45 | |||||
EBIT, 2 Yr. CAGR % | 18.14 | -8.86 | 101.72 | 44.71 | -49.43 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 47.11 | 42.32 | -74.41 | 36.79 | -4.83 | |||||
Net Income, 2 Yr. CAGR % | 47.11 | 37.08 | -65 | 41.93 | -60.86 | |||||
Normalized Net Income, 2 Yr. CAGR % | 14.92 | -7.45 | 86.74 | 32.69 | -49.52 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 46.69 | 37.55 | -63.88 | 51.65 | -57.92 | |||||
Accounts Receivable, 2 Yr. CAGR % | -18.67 | 6.31 | 47.56 | 7.03 | -12.1 | |||||
Inventory, 2 Yr. CAGR % | -3.15 | 6.56 | 29.01 | -1.9 | -9.04 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -7.86 | -7.74 | -3.9 | -3.69 | -2.78 | |||||
Total Assets, 2 Yr. CAGR % | -2.61 | -1.35 | 3.75 | -1.22 | -1.03 | |||||
Tangible Book Value, 2 Yr. CAGR % | -13.23 | -10.69 | -7.17 | -8.12 | -12.56 | |||||
Common Equity, 2 Yr. CAGR % | -15.36 | -12.44 | -2.63 | -3.49 | -6.35 | |||||
Cash From Operations, 2 Yr. CAGR % | -27.08 | -4.28 | 83.45 | 16.49 | -18.34 | |||||
Capital Expenditures, 2 Yr. CAGR % | -14.18 | -15.97 | -0.97 | 14.55 | 12.58 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 12.12 | 105.9 | 103.86 | 10.34 | -37.51 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 11.96 | 77.1 | 94.5 | 11.76 | -34.43 | |||||
Dividend Per Share, 2 Yr. CAGR % | -19.74 | -27.59 | -4.22 | 14.63 | 13.95 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -8.93 | -19.23 | 14.88 | 25.39 | 6.2 | |||||
Gross Profit, 3 Yr. CAGR % | -11.52 | -5.66 | 15.09 | 35.5 | 7.53 | |||||
EBITDA, 3 Yr. CAGR % | -22.04 | -10.18 | 16.77 | 45.15 | 2.33 | |||||
EBITA, 3 Yr. CAGR % | 35.95 | -5.28 | 40.01 | 37.62 | -3.73 | |||||
EBIT, 3 Yr. CAGR % | 36.72 | -6.29 | 39.47 | 36.35 | -6.15 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 81.48 | -3.95 | -31.33 | -8.5 | -47.49 | |||||
Net Income, 3 Yr. CAGR % | 81.63 | -6.93 | -14.83 | -9.12 | -63.07 | |||||
Normalized Net Income, 3 Yr. CAGR % | 32.09 | -7.34 | 36.01 | 27.81 | -9.88 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 80.42 | -7.17 | -12.75 | -5.09 | -60.39 | |||||
Accounts Receivable, 3 Yr. CAGR % | -12.02 | 4.23 | 12.85 | 25.18 | -0.59 | |||||
Inventory, 3 Yr. CAGR % | -3.9 | 9.64 | 10.38 | 10.59 | -0.68 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -3.92 | -5.85 | -7.19 | -3.03 | -3.89 | |||||
Total Assets, 3 Yr. CAGR % | -1.08 | 0.6 | -0.81 | 1.55 | -0.59 | |||||
Tangible Book Value, 3 Yr. CAGR % | -8.42 | -6.8 | -13.86 | -3.17 | -15.06 | |||||
Common Equity, 3 Yr. CAGR % | -10.23 | -8.79 | -11.79 | -0.45 | -7.75 | |||||
Cash From Operations, 3 Yr. CAGR % | -13.71 | 1.07 | 16.68 | 38.11 | 4.95 | |||||
Capital Expenditures, 3 Yr. CAGR % | -9.43 | -13.3 | -7.84 | 5.1 | 12 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 35.11 | 4.99 | 138.04 | 16.07 | 8.06 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 32.87 | 4.64 | 111.51 | 15.54 | 9.58 | |||||
Dividend Per Share, 3 Yr. CAGR % | -13.1 | -19.03 | -16.42 | 2.68 | 13.07 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -4.12 | -2.97 | 0.11 | -6.88 | 3.46 | |||||
Gross Profit, 5 Yr. CAGR % | -4.32 | 6.6 | 13.55 | 7.14 | 0.38 | |||||
EBITDA, 5 Yr. CAGR % | -8.93 | 7.73 | 16.01 | 6.33 | -4.57 | |||||
EBITA, 5 Yr. CAGR % | 54.34 | 103.39 | 37.85 | 11.48 | -6.36 | |||||
EBIT, 5 Yr. CAGR % | 54.86 | 102.08 | 37.54 | 10.86 | -7.78 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 26.5 | 118.09 | -17.11 | 10.64 | -21.75 | |||||
Net Income, 5 Yr. CAGR % | 25.65 | 131.01 | -6 | 10.19 | -37.6 | |||||
Normalized Net Income, 5 Yr. CAGR % | 46.5 | 49.72 | 32.47 | 6.95 | -8.93 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 23.19 | 128.44 | -5.19 | 12.96 | -34.83 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.62 | 9.47 | 8.2 | 5.34 | 2.12 | |||||
Inventory, 5 Yr. CAGR % | 3.59 | 6.08 | 8.11 | 4.87 | 2.16 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -2.41 | -2.74 | -3.91 | -4.99 | -5.45 | |||||
Total Assets, 5 Yr. CAGR % | 0.44 | 1.76 | 0.83 | -0.13 | -0.89 | |||||
Tangible Book Value, 5 Yr. CAGR % | -4.68 | -2.99 | -7.93 | -7.33 | -13.34 | |||||
Common Equity, 5 Yr. CAGR % | -6.03 | -4.56 | -7.27 | -6.71 | -9.65 | |||||
Cash From Operations, 5 Yr. CAGR % | -8.66 | 17.17 | 16.68 | 6.97 | 1.16 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.98 | -8.2 | -6.13 | -3.08 | -0.16 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 27.57 | 34 | 48.5 | 6.73 | 39.38 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 26.77 | 31.47 | 45.27 | 7.1 | 32.37 | |||||
Dividend Per Share, 5 Yr. CAGR % | -8.08 | -11.57 | -9.65 | -6.95 | -5.39 |
- Stock Market
- Equities
- BP. Stock
- Financials BP PLC
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions